Evidence in preclinical models demonstrates that genes other than APP being in three-copies modifies aspects of DSAD, such as cognition and amyloid-β load [68, 1, 47], but more work is required to understand how the molecular processes of AD are altered by trisomy 21 in the brain of people with DS. The gene discussed is APP; the disease is Alzheimer disease.